194 related articles for article (PubMed ID: 29899115)
21. Improved insulin stability through amino acid substitution.
Brems DN; Brown PL; Bryant C; Chance RE; Green LK; Long HB; Miller AA; Millican R; Shields JE; Frank BH
Protein Eng; 1992 Sep; 5(6):519-25. PubMed ID: 1438162
[TBL] [Abstract][Full Text] [Related]
22. Activities of monomeric insulin analogs at position A8 are uncorrelated with their thermodynamic stabilities.
Weiss MA; Hua QX; Jia W; Nakagawa SH; Chu YC; Hu SQ; Katsoyannis PG
J Biol Chem; 2001 Oct; 276(43):40018-24. PubMed ID: 11517220
[TBL] [Abstract][Full Text] [Related]
23. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
[TBL] [Abstract][Full Text] [Related]
24. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues.
Whittingham JL; Edwards DJ; Antson AA; Clarkson JM; Dodson GG
Biochemistry; 1998 Aug; 37(33):11516-23. PubMed ID: 9708987
[TBL] [Abstract][Full Text] [Related]
25. Novel Methods for the Chemical Synthesis of Insulin Superfamily Peptides and of Analogues Containing Disulfide Isosteres.
Hossain MA; Wade JD
Acc Chem Res; 2017 Sep; 50(9):2116-2127. PubMed ID: 28829564
[TBL] [Abstract][Full Text] [Related]
26. Hierarchical protein folding: asymmetric unfolding of an insulin analogue lacking the A7-B7 interchain disulfide bridge.
Hua QX; Nakagawa SH; Jia W; Hu SQ; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2001 Oct; 40(41):12299-311. PubMed ID: 11591149
[TBL] [Abstract][Full Text] [Related]
27. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
[TBL] [Abstract][Full Text] [Related]
28. Insulin fibrillation and protein design: topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir.
Phillips NB; Whittaker J; Ismail-Beigi F; Weiss MA
J Diabetes Sci Technol; 2012 Mar; 6(2):277-88. PubMed ID: 22538136
[TBL] [Abstract][Full Text] [Related]
29. Monomeric B27 Lys destripeptide insulin: semisynthesis, characterization and biological activity.
Ding JG; Cui DF; Zhang YS
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):215-8. PubMed ID: 12621544
[TBL] [Abstract][Full Text] [Related]
30. Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody.
Hinke SA; Cieniewicz AM; Kirchner T; D'Aquino K; Nanjunda R; Aligo J; Perkinson R; Cooper P; Boayke K; Chiu ML; Jarantow S; Lacy ER; Liang Y; Johnson DL; Whaley JM; Lingham RB; Kihm AJ
Mol Metab; 2018 Apr; 10():87-99. PubMed ID: 29453154
[TBL] [Abstract][Full Text] [Related]
31. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
[TBL] [Abstract][Full Text] [Related]
32. Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
Weiss MA; Wan Z; Zhao M; Chu YC; Nakagawa SH; Burke GT; Jia W; Hellmich R; Katsoyannis PG
J Mol Biol; 2002 Jan; 315(2):103-11. PubMed ID: 11779231
[TBL] [Abstract][Full Text] [Related]
33. Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques.
Gillis RB; Solomon HV; Govada L; Oldham NJ; Dinu V; Jiwani SI; Gyasi-Antwi P; Coffey F; Meal A; Morgan PS; Harding SE; Helliwell JR; Chayen NE; Adams GG
Sci Rep; 2021 Jan; 11(1):1737. PubMed ID: 33462295
[TBL] [Abstract][Full Text] [Related]
34. [Rapid-acting insulin analogues].
Matsuda A; Kuzuya T
Nihon Rinsho; 1999 Mar; 57(3):709-18. PubMed ID: 10199158
[TBL] [Abstract][Full Text] [Related]
35. Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente properties.
Richards JP; Stickelmeyer MP; Frank BH; Pye S; Barbeau M; Radziuk J; Smith GD; DeFelippis MR
J Pharm Sci; 1999 Sep; 88(9):861-7. PubMed ID: 10479347
[TBL] [Abstract][Full Text] [Related]
36. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
[TBL] [Abstract][Full Text] [Related]
37. Intra-A chain disulfide bond (A6-11) of insulin is essential for displaying its activity.
Dai Y; Tang JG
Biochem Mol Biol Int; 1994 Aug; 33(6):1049-53. PubMed ID: 7804129
[TBL] [Abstract][Full Text] [Related]
38. Engineering of insulin receptor isoform-selective insulin analogues.
Glendorf T; Stidsen CE; Norrman M; Nishimura E; Sørensen AR; Kjeldsen T
PLoS One; 2011; 6(5):e20288. PubMed ID: 21625452
[TBL] [Abstract][Full Text] [Related]
39. Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets.
Chhabra S; Belgi A; Bartels P; van Lierop BJ; Robinson SD; Kompella SN; Hung A; Callaghan BP; Adams DJ; Robinson AJ; Norton RS
J Med Chem; 2014 Dec; 57(23):9933-44. PubMed ID: 25393758
[TBL] [Abstract][Full Text] [Related]
40. Structure and activity of (2,8)-dicarba-(3,12)-cystino alpha-ImI, an alpha-conotoxin containing a nonreducible cystine analogue.
MacRaild CA; Illesinghe J; van Lierop BJ; Townsend AL; Chebib M; Livett BG; Robinson AJ; Norton RS
J Med Chem; 2009 Feb; 52(3):755-62. PubMed ID: 19125616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
